A new way to make powerful changes at will to the DNA of humans, other animals and plants, much like how a writer changes words in a story, could usher in a transformation in genetic medicine.
Scientists are not just excited about this recently discovered technique because it can snip and edit DNA with precision. It can also do the job more easily and cheaply than other gene-editing methods, making possible research that has historically been difficult, experts say.
Now some of the biologists who unlocked this tool, derived from the immune system of bacteria, are forming companies around it. Although this molecular system, known as Crispr, is not fully understood, researchers believe it can be harnessed to create therapies for intractable genetic diseases.
“In principle, this is a technology that could enable correction of genetic mutations that would otherwise lead to disease,” said Doudna, a professor of chemistry and biochemistry and molecular biology, in a telephone interview. She was among several experts who spoke at a UC Berkeley conference on the subject last month.
Ethical concerns
But because the method is in its infancy and has little precedent with the agencies that regulate medicines, it will almost certainly be a long time before a Crispr-based therapy makes it to market.
Its potential risks also concern some bioethicists.
The Latest on: Editing DNA
[google_news title=”” keyword=”Editing DNA” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Editing DNA
- Lexington to utilize private DNA labs that will help solve cases quickeron April 19, 2024 at 6:31 pm
Soon enough, Lexington Police may have some extra assistance in moving the DNA testing process along even quicker.
- A North Carolina company is trying to make a fungus-proof bananaon April 19, 2024 at 12:02 pm
A deadly fungus could destroy most of the world’s supply of Cavendish bananas, but a company in North Carolina's Research Triangle Park is trying to save the banana through gene editing.
- Fighting Banana Blight In A North Carolina Greenhouseon April 19, 2024 at 10:23 am
America’s most-consumed fruit is at risk from a fungal disease. Researchers in North Carolina are on a mission to save Cavendish bananas.
- Researchers discover dynamic DNA structures that regulate the formation of memoryon April 19, 2024 at 8:28 am
An international collaborative research team, including scientists from UQ's Queensland Brain Institute (QBI), has discovered a novel mechanism underlying memory involving rapid changes in a specific ...
- Korro Announces $70 Million Private Placementon April 18, 2024 at 7:30 am
Financing led by Deep Track Capital with participation from other leading healthcare investorsPro-forma cash and cash equivalents of ...
- Colossal Announces $7.5M in New Investments in Ancient DNA Academic Researchon April 17, 2024 at 3:14 pm
Dr. Beth Shapiro, Colossal Biosciences’ chief science office, will lead the de-extinction company's ancient DNA research and oversee the distribution of funding and development of new partnerships and ...
- NC company helps bring CRISPR to high schoolson April 17, 2024 at 9:21 am
High school students across the country can now easily and affordably perform cutting-edge gene editing thanks to the new CRISPR in a Box educational kit. Burlington-based Carolina Biological Supply ...
- Lilly's Prevail walks away from gene editing collab with Precisionon April 17, 2024 at 5:48 am
Nine months after Eli Lilly’s Prevail Therapeutics reduced the biobucks value of a gene editing deal with Precision Biosciences, the Big Pharma subsidiary has ...
- A blood test to detect cancer? Some patients are using them already.on April 16, 2024 at 3:30 am
New blood tests measure “signals” in the blood to help detect cancer. Experts say more study is needed to determine if the new tests save lives.
- Stanford doctors help develop first FDA-approved gene-editing treatmenton April 9, 2024 at 12:28 am
The FDA recently approved Casgevy, a gene-editing medical treatment which uses CRISPR/Cas9 technology to treat sickle cell disease. Casgevy, which two Stanford faculty members contributed to via drug ...
via Bing News